Korean J Gastroenterol.  1999 Feb;33(2):211-221.

Activities of alpha-D-Mannosidase and beta-D-Mannosidasein Patients with Liver Diseases

Abstract

BACKGROUND/AIMS: We studied the activities of alpha- and beta-D-mannosidase to evaluate their diagnostic significance in liver diseases.
METHODS
One hundred fifty one patients with liver diseases were en rolled. The activities of the enzymes were measured by microquantitative spectrophotometry.
RESULTS
The activities of alpha-D-mannosidase isozymes (neutral and intermediate alpha-D-mannosidase) were signif icantly high in patients with icteric acute hepatitis (IAH)(48.4 +/-25.4, 17.6 +/-12.9, 12.2 +/-6.2), anicteric acute hepatitis (AAH)(29.9 +/-16.0, 11.9 +/-5.3, 10.2 +/-3.1), cholestatic hepatitis (ChH) (118.3 +/-20.6, 50.3 +/-12.2, 37.0 +/-5.5), icteric liver cirrhosis (ILC)(36.6 +/-13.5, 12.0 +/-7.8, 9.6 +/-4.3), ILC with hepa tocellular carcinoma (HCC)(39.0 +/-16.5, 15.1 +/-9.4, 11.1 +/-5.8). The activity of beta-D- mannosidase was also significantly high in patients with IAH (212 +/-36), icteric chronic hepatitis (ICH)(193 +/-25), ACH (196 +/-25), ChH (252 +/-38), ILC (188 +/-21), ILC with HCC (217 +/-55), and ALC with HCC (203 +/- 34).
CONCLUSIONS
The activities of alpha- and beta- D-mannosidase were significantly increased in liver diseases with jaundice, which was related to the increased permeability of the liver cell membrane and the leakage of the enzymes into the blood in large quantities. Serial measurement of these enzymes will be helpful to diagnose liver diseases and to understand the clinical conditions of the patients.

Keyword

Liver disease; alpha- &beta-D-Mannosidase

MeSH Terms

alpha-Mannosidase*
beta-Mannosidase
Cell Membrane
Hepatitis
Hepatitis, Chronic
Humans
Isoenzymes
Jaundice
Liver Cirrhosis
Liver Diseases*
Liver*
Permeability
Spectrophotometry
Isoenzymes
alpha-Mannosidase
beta-Mannosidase
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr